Robin Farias‐Eisner

5.1k total citations · 1 hit paper
69 papers, 3.8k citations indexed

About

Robin Farias‐Eisner is a scholar working on Molecular Biology, Reproductive Medicine and Surgery. According to data from OpenAlex, Robin Farias‐Eisner has authored 69 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Reproductive Medicine and 17 papers in Surgery. Recurrent topics in Robin Farias‐Eisner's work include Ovarian cancer diagnosis and treatment (19 papers), Cancer, Lipids, and Metabolism (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Robin Farias‐Eisner is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Cancer, Lipids, and Metabolism (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Robin Farias‐Eisner collaborates with scholars based in United States, Canada and China. Robin Farias‐Eisner's co-authors include Srinivasa T. Reddy, Feng Su, Ling Wang, Dilprit Bagga, John A. Glaspy, Ernesto E. Aeberhard, M. Amneus, Katherine R. Kozak, Gautam Chaudhuri and Kym F. Faull and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Robin Farias‐Eisner

67 papers receiving 3.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion

2003 512 citations Robin Farias‐Eisner, Srinivasa T. Reddy et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Farias‐Eisner United States	34	1.5k	878	798	665	471	69	3.8k
Sara Bassilian United States	31	2.1k 1.5×	735 0.8×	343 0.4×	107 0.2×	238 0.5×	63	3.3k
Kristin M. Nieman United States	19	1.9k 1.3×	1.7k 1.9×	314 0.4×	283 0.4×	981 2.1×	42	4.0k
Hiromasa Tojo Japan	32	1.6k 1.1×	160 0.2×	390 0.5×	115 0.2×	279 0.6×	111	2.9k
Brian L. Hood United States	38	2.7k 1.9×	576 0.7×	215 0.3×	128 0.2×	577 1.2×	105	4.4k
Coby Meijer Netherlands	38	2.0k 1.4×	653 0.7×	965 1.2×	193 0.3×	2.8k 6.0×	114	5.2k
Alane Koki United States	25	1.6k 1.1×	1.1k 1.2×	541 0.7×	74 0.1×	1.1k 2.4×	38	6.2k
Jonathan E. McDunn United States	32	1.9k 1.3×	467 0.5×	300 0.4×	89 0.1×	350 0.7×	53	4.3k
Pierre Formstecher France	35	2.4k 1.6×	344 0.4×	325 0.4×	143 0.2×	481 1.0×	114	3.9k
Wayne A. Phillips Australia	43	4.1k 2.8×	1.3k 1.4×	1.1k 1.3×	215 0.3×	2.3k 5.0×	169	7.2k
Edward R. Sauter United States	44	3.2k 2.2×	1.8k 2.1×	696 0.9×	55 0.1×	1.6k 3.4×	198	7.0k

Countries citing papers authored by Robin Farias‐Eisner

Since Specialization

Citations

This map shows the geographic impact of Robin Farias‐Eisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Farias‐Eisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Farias‐Eisner more than expected).

Fields of papers citing papers by Robin Farias‐Eisner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Farias‐Eisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Farias‐Eisner. The network helps show where Robin Farias‐Eisner may publish in the future.

Co-authorship network of co-authors of Robin Farias‐Eisner

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Farias‐Eisner. A scholar is included among the top collaborators of Robin Farias‐Eisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Farias‐Eisner. Robin Farias‐Eisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dempsey, Michael P., et al.. (2023). Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic Peptide. International Journal of Molecular Sciences. 24(12). 10054–10054.

Conrad, Lesley B., et al.. (2023). Understanding Health Disparities in Preeclampsia: A Literature Review. American Journal of Perinatology. 41(S 01). e1291–e1300. 6 indexed citations

Devarajan, Asokan, Feng Su, Víctor Grijalva, et al.. (2018). Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death and Disease. 9(3). 392–392. 27 indexed citations

Liang, Margaret, Deanna H. Wong, Christine Walsh, Robin Farias‐Eisner, & Joshua G. Cohen. (2017). Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers. Journal of Genetic Counseling. 27(1). 177–186. 20 indexed citations

Sen, Suvajit, Sushil K. Mahata, Rebecca Tsai, et al.. (2016). Cystathionine: A novel oncometabolite in human breast cancer. Archives of Biochemistry and Biophysics. 604. 95–102. 39 indexed citations

Gao, Feng, Bin Liang, Srinivasa T. Reddy, Robin Farias‐Eisner, & Xiulan Su. (2014). Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis. Current Cancer Drug Targets. 14(1). 30–45. 53 indexed citations

Chattopadhyay, A., Mohamad Navab, Greg Hough, et al.. (2013). A novel approach to oral apoA-I mimetic therapy. Journal of Lipid Research. 54(4). 995–1010. 73 indexed citations

Sen, Suvajit, Brian Kawahara, N.L. Fry, et al.. (2013). A light-activated NO donor attenuates anchorage independent growth of cancer cells: Important role of a cross talk between NO and other reactive oxygen species. Archives of Biochemistry and Biophysics. 540(1-2). 33–40. 9 indexed citations

Devarajan, Asokan, Ines Witte, Petra Wilgenbus, et al.. (2012). PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death and Differentiation. 19(9). 1549–1560. 71 indexed citations

10.

Ganapathy, Ekambaram, Feng Su, David Meriwether, et al.. (2011). D‐4F, an apoA‐I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. International Journal of Cancer. 130(5). 1071–1081. 57 indexed citations

11.

Gao, Feng, Feng Su, Neha Shah, et al.. (2011). L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integrative Biology. 3(4). 479–479. 62 indexed citations

12.

Su, Feng, Víctor Grijalva, J. H. Pope, et al.. (2011). Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium. PLoS ONE. 6(4). e19099–e19099. 50 indexed citations

13.

Farias-Eisner, Gina, et al.. (2009). Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. American Journal of Obstetrics and Gynecology. 202(1). 73.e1–73.e5. 44 indexed citations

14.

Nosov, Vladimir, et al.. (2009). Predictors of Recurrence of Ovarian Granulosa Cell Tumors. International Journal of Gynecological Cancer. 19(4). 628–633. 24 indexed citations

15.

Su, Feng, Katherine R. Kozak, Harvey R. Herschman, Srinivasa T. Reddy, & Robin Farias‐Eisner. (2007). Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells. Journal of Neuroscience Research. 85(9). 1952–1958. 6 indexed citations

16.

Pakneshan, Pouya, Moshe Szyf, Robin Farias‐Eisner, & Shafaat A. Rabbani. (2004). Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis. Journal of Biological Chemistry. 279(30). 31735–31744. 148 indexed citations

17.

Memarzadeh, Sanaz, Katherine R. Kozak, Sathima Natarajan, et al.. (2002). Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proceedings of the National Academy of Sciences. 99(16). 10647–10652. 66 indexed citations

18.

Elkas, John C. & Robin Farias‐Eisner. (1998). Cancer of the uterine cervix. Current Opinion in Obstetrics & Gynecology. 10(1). 41–45. 9 indexed citations

19.

Casey, A.Catherine, Robin Farias‐Eisner, Frank D. Cirisano, et al.. (1996). What Is the Role of Reassessment Laparoscopy in the Management of Gynecologic Cancers in 1995?. Gynecologic Oncology. 60(3). 454–461. 29 indexed citations

20.

Farias‐Eisner, Robin & Jonathan S. Berek. (1993). Current Management of Invasive Squamous Carcinoma of the Vulva. Clinics in Geriatric Medicine. 9(1). 131–143. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact